Health sciences and technologies Luxembourg's health sciences and technologies sector has considerably developed over the past few years, and currently specialises in the fields of personalised medicine, diagnostics, bioinformatics and e-Health. The government’s firm commitment to establishing the country as an attractive destination for health sciences research and innovation is backed by substantial public investment and a supportive business environment. Companies – often SMEs – as well as public research laboratories are active in a variety of fields in Luxembourg, such as biomedical analyses, compound and biomarker discovery, dental and orthopaedic implants, laboratory and hospital equipment and health-related ICT applications. Companies include, among others, Advanced Biological Laboratories, Ketterthill, Laboratoires Réunis, Waftergen Biosystems Europe and innovative start-ups such as AI Mediq. Biotechnology and health sciences have been a key element of the government's strategy to diversify the Luxembourg economy since 2006. The further development of the sector is being supported by an ambitious national action plan, which aims to develop the country as a centre of excellence in molecular diagnostics, the main pillar of personalised medicine. World-renowned health research institutes Key research actors include the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, a leading research institute that aims to accelerate biomedical research by closing the link between systems biology and medical research. Its research focuses on neurodegenerative diseases such as Parkinson’s disease, metabolomics and disease network analysis. The Luxembourg Institute of Health (LIH) is recognised by the international scientific community for its excellence in biomedical research and public health. Its research activities are concentrated on the areas of oncology, infection and immunity and population health. The LIH also integrates the IBBL (Integrated BioBank of Luxembourg), whose mission is to provide high-quality biospecimens and associated data, foster scientific excellence, catalyse partnerships and support research that translates scientific discoveries into new healthcare solutions. To support research and to make the country a global leader in incorporating personalised medicine into the national healthcare system, the IBBL, the LIH and the LCSB have jointly set up the Personalised Medicine Consortium (PMC), which supports research programmes in personalised healthcare. Luxembourg’s biomedical research community also includes researchers working at the Luxembourg Institute of Science and Technology (LIST) and the Laboratory of Molecular and Cellular Cancer Biology (LBMCC). A supportive environment The Luxembourg BioHealth Cluster has been set up to further develop the sector and promote its capacities at international level. It brings companies and research laboratories together to create collaborations and identify new business opportunities. The Cluster also supports international companies interested in setting up activities in Luxembourg or establishing cooperations with Luxembourg entities. Luxembourg’s excellent support infrastructure for start-ups and foreign companies wishing to locate activities here includes the House of Biohealth, a life sciences focused hosting and incubation facility.
